Dr. Munver Discusses Kidney Cancer Research and Innovation
It has been 20 years since robotic surgery started at Hackensack University Medical Center. Watch Dr. Ravi Munver discuss 3D anatomical modeling technology for preoperative surgical planning and intraoperative navigation during robotic kidney surgery.
70% all kidney cancers treated with partial nephrectomy
95% Advanced Robotic Minimally Invasive Surgery
4 years 1,137 Kidney cancer Surgeries
Average length of stay 2 days
In the past four years we have completed:
Leader in Robotic Training
Urologists from around the country come to Hackensack University Medical Center for training in the latest robotic techniques used to treat kidney cancer. Our surgeons have published and presented more than 50 papers on the management of kidney cancer, with some of the best outcomes worldwide.
Our urologists are experts in a range of surgical approaches. Your treatment is tailored to your specific condition, the location and size of your tumor, and your overall health.
- Robotic-Assisted and Laparoscopic Surgery
The majority of kidney cancer surgeries at Hackensack are performed using robotic-assisted procedures. In these procedures, surgery is performed through very small incisions in the lower abdomen using robotic surgical instruments aided by a highly sophisticated three-dimensional camera. These minimally invasive surgeries offer significant advantages, including less blood loss, less damage to the kidney, and a shorter hospital stay. Additionally, our robotic systems use near-infrared fluorescent imaging that ensures we remove the entire cancer while minimizing any damage to the healthy kidney.
- Open Surgery
Open surgery may be recommended for people who have large, complex or advanced tumors, or tumors affecting multiple nearby organs. All of our surgeons are trained using advanced open surgical techniques and, when required, use a multisurgical approach in collaboration with Hackensack vascular and general surgeons.
Percutaneous cryoablation is a procedure in which small tumors are frozen and destroyed. This technique can be used if the tumor is easily reached through the back or side of the body. Cryoablation offers treatment options to people who otherwise could not have surgery; however, there may be a greater chance of recurrence than with other surgical procedures.
- Active Surveillance
For elderly patients with small tumors, we may choose active surveillance. We perform periodic magnetic resonance imaging (MRI) and occasionally biopsy (removing a small sample of the tumor for analysis) to minimize the need for surgery on tumors that are benign or not aggressive.
Medical Treatments for Kidney Cancer
Kidney-sparing therapies and procedures can help you maintain your quality of life after kidney cancer treatment. Hackensack surgeons and medical oncologists work closely together to develop a personalized treatment plan that may combine anticancer medications with surgery to achieve the best possible outcome.
Our medical oncologists participate in a range of kidney cancer clinical trials that provide you with access to the latest, most promising chemotherapy, immunotherapies, and targeted treatments.
Depending on your specific situation, your kidney cancer treatment plan may include:
- Targeted therapy with drugs that shrink or slow the growth of kidney cancers. Sunitinib, a drug that slows cancer growth, can be used to treat early-stage kidney cancer, or after surgery for more advanced cases of kidney cancer.
- Immunotherapy, which uses medications to help your immune system fight cancer. Immunotherapy can be used to treat advanced cases of kidney cancer, kidney cancer that is not responding to targeted treatment, or disease that has spread to other areas of your body. Sometimes immunotherapy can be combined with certain targeted treatments
- Chemotherapy, which treats cancer using medications given through an intravenous (IV) injection or pill and which travel throughout your body. Kidney cancer does not usually respond well to chemotherapy, but chemotherapy may be used if targeted treatment or immunotherapy is not working.